2025. Managing Bevacizumab-Related Gastrointestinal Perforation In Hepatocellular Carcinoma (HCC) Patients: A Systematic Review. The Review of Diabetic Studies . (Feb. 2025), 1039–1048. DOI:https://doi.org/10.70082/x94dvz94.